Kinaset Therapeutics, Inc. — Form D/A

Kinaset Therapeutics, Inc. of MEDFIELD, MA, a company, filed a Form D amendment with the SEC on 2023-07-17. The offering totals $41.0M, of which $28.5M was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2023-07-17
Form: D/A
Accession: 0001821223-23-000001
Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $41.0M
Amount sold: $28.5M
Remaining: $12.5M
Minimum investment: $7.1M
Investors: 3
Date of first sale: 2022-07-05
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-452720

Issuer

Name: Kinaset Therapeutics, Inc.
CIK: 0001821223
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2020
Address: 10 KNOLLWOOD ROAD, MEDFIELD, MA, 02052
Phone: (508) 858-5810

Officers, directors & promoters (11)

Name	Role	Location
Jamil Beg	Director	Cambridge, MA
Kevin Bitterman	Director	Cambridge, MA
Robert Clarke	Director	Dover, DE
Tom King	Director	Medfield, MA
Bram Vanparys	Director	Medfield, MA
Robert Clarke	Executive Officer	Dover, DE
Roger Heerman	Executive Officer	Medfield, MA
Frazer Morgan	Executive Officer	Medfield, MA
Robert Clarke	Promoter	Dover, DE
Roger Heerman	Promoter	Medfield, MA
Frazer Morgan	Promoter	Medfield, MA

Other filings by this issuer (2)

Filed	Form	Offering	Sold
2022-07-18	D	$41.0M	$28.5M
2020-08-17	D	$40.0M	$1.5M

More